|
|
||||||||
Department of Thoracic and Cardiovascular Surgery, Clinical Research Institute, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Accepted for publication August 21, 2007.
* Address correspondence to Dr Kim, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-744, South Korea (Email: ytkim{at}snu.ac.kr).
| Abstract |
|---|
|
|
|---|
Methods: We retrospectively analyzed patients with cold abscess of the chest wall, focusing on their clinical features, surgical results, and the long-term outcome. Eighty patients were enrolled between May 1981 and April 2005. There were 35 male and 45 female patients, who underwent surgical treatment for cold abscess of the chest wall. The mean age of the patients was 31.4 ± 12.5 (14 to 73) years. Forty patients (50.0%) had previous history of pulmonary tuberculosis. A growing chest wall mass was present in every patient. Surgical treatments performed were as follows: abscess debridement and drainage in 15 (18.8%), complete excision of the abscess without chest wall resection in 9 (11.2%), and complete excision of the abscess including chest wall in 56 patients (70.0%).
Results: There were no cases of operative mortality. Operative morbidity developed in four patients; two wound infections, one pneumonia, and one prolonged chest tube drainage. Postoperative antituberculous medication was given to all patients. Twelve patients (15.0%) recurred and required a second operation. The recurrence rate was higher in patients where only drainage of the abscess was performed compared with those in whom complete resection was performed (40.0% vs 9.2%, p = 0.008).
Conclusions: Cold abscess of the chest wall can be surgically managed successfully with low operative risk. Complete resection of the abscess, including a portion of the involved chest wall, is mandatory to avoid recurrence.
| Introduction |
|---|
|
|
|---|
| Patients and Methods |
|---|
|
|
|---|
2 and log-rank tests. Recommendations from the Declaration of Helsinki for Biomedical Research involving Human Subjects were also followed. The study protocol as well as ethical issues were reviewed and approved by the Seoul National University Hospital Institutional Review Board, and the need for patient consent for the study was waived.
|
|
| Results |
|---|
|
|
|---|
Surgical treatments performed were as follows: abscess debridement and drainage in 15 patients (18.8%), complete excision of the abscess without rib resection in 9 (11.2%), and complete excision of the abscess with soft tissue as well as bony chest wall including rib, sternum, or part of clavicle in 56 patients (70.0%); right rib in 41 patients, left rib in 13, a portion of sternum in 4, and a portion of clavicle in 1. A total of 107 ribs (mean = 1.34/patient) were resected. Soft tissue reconstruction was performed in 14 cases using the latissimus dorsi in eight, the pectoralis major in three, the serratus anterior in one, both latissimus dorsi and serratus anterior in one, and skin graft in one patient. Skeletal reconstruction was performed in four cases; two with GoreTex mesh (W. L. Gore Associates, Flagstaff, AZ), one with Marlex mesh, and one with autologous rib.
The mean hospital stay was 14 days (5 to 60 days). There were no cases of operative mortality. Operative morbidity developed in four patients including two wound infections, one postoperative pneumonia, and one prolonged chest tube drainage. All complications were successfully managed in a conservative manner.
The typical microscopic features with epithelioid histiocytes and caseous necrosis were found in all cases (Fig 2). The AFB were grown in the specimen culture of eight patients. Postoperative antituberculous chemotherapy was given to every patient. Twenty-nine patients were treated for 6 months, 27 for 9 months, 17 for 12 months, and 6 patients received tuberculosis medication for more than one year. The medication given was isoniazid, ethambutol, and rifampicin in 34 patients, isoniazid, ethambutol, rifampicin, and pyrazinamide in 41, isoniazid, ethambutol, rifampicin, and levofloxacillin in 4, and cycloserine, prothionamide, and levofloxacin in one.
During the mean follow-up period of 71.1 ± 66.9 (26 to 263) months, eight patients were lost in that time. Twelve patients (15.0%) recurred at the same site and required further treatment. Recurrence occurred in six patients (40.0%), who were treated with debridement and drainage only, whereas recurrence developed in only six patients (9.2%) after wide excision of soft tissue with or without resection of ribs and sternum (p = 0.008,
2 test; Fig 3). After the debridement and drainage only procedure, recurrence occurred at immediate postoperative period in one patient, at 2 months in one, at 1 year in two, and at 6 years and 7 years in one patient each. Two patients were subsequently treated by wide resection with tuberculous medication and did not report recurrence thereafter. Four patients were treated with repeated drainage and debridement with antituberculosis medication. Among them, one was cured, two recurred after the second operation, and one was lost during follow up without healing of the abscess wound. Six cases of recurrence among patients who received wide complete resection occurred at 2 months in two patients and at 8 months, 1 year, 2.5 years, and 10 years in one patient each. Among them, four patients were treated with a second wide resection and reported no recurrence thereafter. One patient was treated with wound care and was cured. The remaining one patient was treated with antituberculous medication and was lost from follow-up (Table 1).
|
|
| Comment |
|---|
|
|
|---|
It was interesting that the AFB grew in only eight resected specimens in our series compared to 60% to 80% of culture positive results in other studies [4, 5]. We do not have a clear explanation for this observation. However, recent use of more sensitive diagnostic tools, such as polymerase chain reaction for AFB, may increase the bacteriologic detection rates. We also found nine bacteria or fungus growth in the culture of the resected specimen, including six Staphylococcus species and Pseudomonas, Klebsiella, and Aspergillus species in each one. Among them, Pseudomonas and Klebsiella species were identified in patients whose abscess aggravated to form a cutaneous fistula. We were not able to find any correlation between mixed bacterial infection and clinical outcome. Hence, we presume the Staphylococcus and Aspergillus species could have been contaminants.
It has been reported that the chest wall cold abscess occurs more frequently in men [4, 6, 9]. In our series, however, women were affected more frequently than men. There are different reports with regards to the frequently affected age. While some authors reported more frequent incidence at a younger age (15 to 35 years) [7, 9, 10], others reported a higher rate at an older age [4, 6, 11]. In our current series, 73% of the patients were younger than 35 years, and only 7 patients (9%) were older than 50 years.
There are a few reports [6, 11, 12] on the successful treatment of chest wall cold abscess with only antituberculous chemotherapy. However, the number of patients in those reports is small and the follow-up was too short. Other authors [4, 5] have reported frequent recurrence of cold abscess by treatment with antituberculous medication only. In our experience, 29 patients were treated with antituberculous medication preoperatively for 1 to 8 months. However, the lesion did not heal and eventually needed surgical resection.
Although surgical resection of the abscess usually provides a definite diagnosis and therapy, there are controversies with regard to the treatment approach. Weissberg [13] suggested performing drainage of the abscess for the purpose of tissue diagnosis followed by antimicrobials treatment, reserving debridement and excision only for the most extensive diseases. Sakuraba and colleagues [5] and Faure and colleagues [4] reported that the majority of patients whose abscess were drained first, needed excision for the definite treatment. We also noticed that the cold abscess was rarely treated by antituberculous medication. Although we tried preoperative antituberculous chemotherapy to reduce the size of the abscess and minimize the extent of the chest wall resection, the abscess did not usually respond to the medical treatment, and eventually surgical excision was necessary.
With regard to the extent of chest wall resection, surgical debridement, including resection of the necrotic ribs, cartilages, and visible adenopathies, has been traditionally recommended. However, there is no clear definition of the extent of resection. Previous reports showed a low rate of recurrence. However, the number of patients was too small and the follow-up period was too short [4–6]. Although we experienced slightly high recurrence rates (13.8%), it is noteworthy that we experienced recurrence even after 7 to 10 years from the initial operation. Paik and colleagues [14] reported their experience of 89 patients during 30 years and indicated 7.8% recurrence rates, with one case in which recurrence developed 12 years after surgery. Given the indolent nature of tuberculosis it is important to evaluate the success of treatment by making careful observations for a significant period of time. We classified the surgical method into debridement and drain only and complete resection with or without skeletal resection based on the operation record. We found the recurrence rates were more frequent after debridement and drain only. This result suggests complete resection of the abscess, including all the abscess wall and adjacent bony chest wall, can reduce postoperative recurrence. However, extensive chest wall resection may result in an unnecessary large operative scar or chest wall deformity and sometimes the extent of resection can be compromised. We found no imaging study was helpful in deciding the extent of chest wall resection. The final decision of the resection extent was determined based on the intraoperative finding. We did our best effort to make the extent of resection as small as possible, while removing all the infected tissue. Usually the situation when rib resection was mandatory was when there was a fistulous tract underneath the ribs. Sometimes, the fistulous tract was connected to the lymph nodes located on the inner surface of the chest cage, which supports the hypotheses that the chest wall cold abscess can be caused by direct extension from lymphadenitis of the chest wall [4]. However, we were not able to clearly identify how many patients showed such operative findings in our series.
A previous report [4] suggested antituberculous medication can prevent long-term recurrence. However, in our experience, all 12 patients who experienced recurrence were treated with postoperative antituberculous medication for longer than 12 months with the exception of two patients who were treated for 2 and 6 months. We agree and recommend treating patients after surgical resection with antituberculous medication. However, it seems that the completeness of the abscess is the more important factor in determining the development of recurrence.
In conclusion, we noticed that complete resection of the cold abscess could be achieved without significant morbidity and could reduce recurrence rates. Based on this result, we recommend that a chest wall cold abscess should be treated by complete resection, including all of the involved area, as well as by the appropriate antituberculous chemotherapy.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Deng, Q.-Y. Tan, R.-W. Wang, Y. He, Y.-G. Jiang, J.-H. Zhou, and Y.-G. Liang Surgical strategy for tubercular abscess in the chest wall: experience of 120 cases Eur J Cardiothorac Surg, January 12, 2012; (2012) ezr209v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tanaka, M. Aoki, T. Nakanishi, Y. Otake, M. Matsumoto, T. Sakurai, K. Tada, and A. Ikeda Retrospective case series analysing the clinical data and treatment options of patients with a tubercular abscess of the chest wall Interact CardioVasc Thorac Surg, December 18, 2011; (2011) ivr113v1. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |